Saince to tap electronic prescription market in India

The app can help patients keep track of all of their prescriptions including the history, resulting in better utilisation of drugs and this minimising any ill effects from them.

By Author   |   Published: 16th Jan 2017   11:11 am Updated: 17th Jan 2017   12:04 pm
Saince
Saince’s app can help doctors alert their patients on recalled drugs

Hyderabad: Hyderabad-based Saince HealthTech, a subsidiary of Saince Inc, a US-based entity, which introduced its mobile-based electronic prescription application, RapiRx, in June last year is keen to capture opportunities in the Indian electronic prescription market.

The parent company based in Atlanta, US, offers clinical documentation, integrity and medical imaging services, serving several hospitals.

Raghuvir Vedantham, President and CEO, Saince HealthTech, told Telangana Today, “We are working on a next version of the app that will issue alerts to doctors if they are prescribing drugs that have drug-drug reactions, inform about drug recalls to further communicate to their patients.”

Explaining RapidRx, he said, the doctors can download the free app from the app store. They get registered. “We get an alert that a doctor has registered, we carry out due diligence to verify the licence (usually a two-hour process). The application enables access to a comprehensive database of over 26,000 licensed drugs sold in the country. Once the prescription is ready, a text message is sent to the patient, and the patient can show the prescription at a drug store.

Drug stores can accordingly dispense it. In cases where a patient is remote or if the prescription is needed in follow up to the treatment already begun, this can be handy. Doctors can also create a favourite list of drugs for prescription. The app is designed for India and introduced for the country.”

The app can help patients keep track of all of their prescriptions including the history, resulting in better utilisation of drugs and this minimising any ill effects from them.

The app is free to use for doctors. It is available as a smartphone app and also on the web portal. He added, the company is working with Ministry of Health, Medical Council of India and Indian Medical Association to create awareness, promote e-prescriptions and to vet the app. “We do not need any regulatory clearances to roll out our offerings in India,” he informed.

The company targets to enroll at least 25,000 doctors in India in the first phase. India has an estimated one million licensed doctors, who write about 3.5 billion prescriptions annually and 10 million prescriptions a day.

On revenues and growth plans, he said, “We already offer clinical documentation and integrity services in India. We have 275 direct and indirect personnel in Hyderabad and we plan to double in next one-two years. “